Ends: 81d 4h 40min
Innovative therapies for skin diseases
Maximising the value of your preclinical assets to find a breakthrough therapy for patients.
Our Aim
We are looking for partnering opportunities on new assets (e.g. new chemical entities, biologics and advanced therapies) at advanced Research or preclinical Development stage.
The proposed asset should demonstrate a scientific rationale and therapeutic potential for treating dermatological conditions.
Our interest
New assets in advanced Research or preclinical Development stages
What we offer
Access to our expertise in dermatological R&D
Your benefit
A partnership opportunity
Shared goal
Finding innovative therapies for patients
Who is this for?
Universities
Biotechs
Public and private Research institutions
Start-ups
Pharmaceutical companies
For scientists at Universities, Research institutions, biotechs, start-ups and pharmaceutical companies
Open from 22/07/20 to 31/10/20
Pharmacological profile of your asset & partnership opportunity
Collaborative framework
Submitted proposals may be eligible for a Research or preclinical Development partnership
You will retain ownership of any intellectual property you may bring or develop
Assets might be characterised on key dermatological in vitro and in vivo assays
A designated contact person will help answer your questions
Submitted proposals may be eligible for a Research or preclinical Development partnership
You will retain ownership of any intellectual property you may bring or develop
Assets might be characterised on key dermatological in vitro and in vivo assays
A designated contact person will help answer your questions
Collaboration process
Collaboration process
1
Proposal submission
From July 22nd, 2020 to October 31st, 2020
2
Submissions will be handled following all aplicable local compliance requirements
3
Proposal evaluation and selection
Within 4-8 weeks after submission
